心脏毒性
多糖
药理学
材料科学
癌症研究
细胞毒性
生物活性
毒性
癌症
生物化学
作者
Yi-fei Gao,Yang Yu,Jia-hua Wang,Liyan Wang,Ya-ni Zhang,Ruibo Guo,Ying Zheng,Mei-jun Lv,Juan Zang,Yang-yang Deng,Wei Chen,Ni Zhang,Q Wang,Xuetao Li,Liang Kong
标识
DOI:10.1016/j.matdes.2026.116852
摘要
Doxorubicin (DOX) is widely applied in cancer chemotherapy, yet it induces severe side effects. Ferroptosis, an iron-dependent form of cell death, plays an important role in the pathogenesis of DOX-induced cardiotoxicity (DIC). Liquiritigenin (LQ) has potent antioxidant activity, and its active components have shown considerable potential for alleviating DIC. In this study, we developed LQ-glycyrrhiza polysaccharide (GP) self-assembled nanomicelles (AngA-LQ-GP@Ms) for the targeted delivery of LQ to cardiomyocytes to suppress oxidative stress and ferroptosis. We found that AngA-LQ-GP@Ms exhibited perfect myocardial-targeting capability both in vitro and in vivo , significantly improved cardiac function in DIC mice, restored mitochondrial structure, alleviated oxidative stress and apoptosis, and effectively inhibited ferroptosis. Furthermore, molecular docking, molecular dynamics simulations, and Cellular Thermal Shift Assay suggested (CETSA) that nuclear factor erythroid 2-related factor 2 (Nrf2) could be a direct target of AngA-LQ-GP@Ms. We further confirmed that blocking Nrf2 expression in cardiomyocytes partially abolished the cardioprotective and antiferroptotic effects of AngA-LQ-GP@Ms in vitro . Therefore, the protective effects of AngA-LQ-GP@Ms against DIC may be partially mediated through the Nrf2 pathway via the inhibition of ferroptosis, thereby providing valuable insights and experimental evidence for the development of targeted therapeutic strategies to alleviate DIC by suppressing ferroptosis in cardiomyocytes.
科研通智能强力驱动
Strongly Powered by AbleSci AI